Sign in

NCT05183763Active, not recruiting

Medication Adherence Program

Supporting Tailored Adaptive Change and Reinforcement for Medication Adherence Program: Randomized Trial of a Novel Approach to Improve Adherence in Older Hypertensive Women and Men

Source: ClinicalTrials.gov · Last updated 1 Oct 2026

Brief summary (registry, in English)

Randomized controlled trial testing the efficacy of the Supporting Tailored Adaptive change and Reinforcement for Medication Adherence Program (STAR-MAP), a health coaching approach that aims to improve antihypertensive medication adherence, blood pressure control, and quality of life. Participants (n=402) \>=40 years old with a diagnosis of hypertension, uncontrolled blood pressure, and low antihypertensive medication adherence will be recruited through a statewide health insurer, Blue Cross Blue Shield of Louisiana, and randomized to receive either interactive health coaching sessions with medication reminder tools (intervention) or medication reminder tools only (control) over one year. Data will be collected from participants at baseline, 6 months, 12 months, and 24 months using questionnaires, physical measurement (height, weight, blood pressure), a computer-based single-category implicit association test, and laboratory analysis of antihypertensive medication urinary metabolites.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
402 (estimated)
First submitted
17 Dec 2021
Start date
7 Mar 2022
Primary completion date
30 Apr 2027
Lead sponsor
Tulane University
NCT number
NCT05183763

What you commit to

  • Study type: Interventional
  • Planned participants: 402
  • From 7 Mar 2022 to the primary completion date, 30 Apr 2027
  • 5 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • enrollment in another clinical trial for drug adherence or BP control

Other illness

  • moderate to severe cognitive impairment

Other

  • living in a household with someone already enrolled in the study

Who the study is looking for

  • fully insured by Blue Cross Blue Shield of Louisiana (BCBSLA)
  • continuously enrolled in BCBSLA for one year
  • planning to remain a member of BCBSLA for next year
  • English-speaking
  • telephone access
  • aged ≥40 years
  • diagnosis of essential hypertension (ICD-10-CM code I10)
  • currently filling antihypertensive medication
  • low antihypertensive medication refill (proportion of days covered (PDC) \<0.8)
  • low self-report adherence (4-item Krousel-Wood Medication Adherence Scale (K-Wood-MAS-4) score ≥1)
  • uncontrolled blood pressure (BP) (systolic BP ≥130 mm Hg or diastolic BP ≥80 mm Hg)
  • desire to improve BP

Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (5)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Pennington Biomedical Research Center
Coordinator of this site? Confirm its status		Baton RougeUnited StatesUnknown status
Tulane Doctors Dermatology & Multispecialty Clinic
Coordinator of this site? Confirm its status		CovingtonUnited StatesUnknown status
Tulane Doctors Heart & Vascular and Primary Care Clinic
Coordinator of this site? Confirm its status		MetairieUnited StatesUnknown status
Tulane University Clinical and Translational Unit
Coordinator of this site? Confirm its status		New OrleansUnited StatesUnknown status
LSU Health Sciences Shreveport Clinical Trials Office
Coordinator of this site? Confirm its status		ShreveportUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.